Kellogg retina surgeons implant Argus II Retinal Prosthesis, or ‘bionic eye,’ for two patients with end-stage retinitis pigmentosa ANN ARBOR, Mich. — Retina surgeons at the University of Michigan Kellogg Eye Center have performed the first – and second – surgeries in the United States to implant an artificial retina, or “bionic eye,” since the U.S. Food and [Read More]
News
Glaucoma: The "Silent Thief of Sight"
Courtesy: National Eye Institute, National Institutes of Health (NEI/NIH) Glaucoma is sometimes called the “silent thief of sight” because it slowly damages the eyes and can cause irreparable harm before there is any vision loss. But this disease is stealthy in more ways than one. Glaucoma has been known at least since antiquity, and yet, [Read More]
20 Things Eye Doctors Probably Don’t Tell You (But Would Like You To Know)
by Dan Roberts Optometrists and ophthalmologists are human. And like the rest of us humans, they can get tired, impatient, frustrated, despondent, and hurt. Unfortunately, professional decorum requires that they maintain a good front by either bottling up their thoughts or venting them at home–neither of which are necessarily good options. For that reason, I [Read More]
Findings Help Predict AMD Advancement
A 10-year follow-up study of participants in the original AREDS trial has been completed. The Age-Related Eye Disease Study Research Group revealed new statistics on the risk and rate of progression from early to advanced age-related macular degeneration (AMD). Participants aged 55 to 80 years with no AMD or AMD of varying severity were followed [Read More]
Choroideremia Gene Therapy Showing Promise
Researchers at Oxford University have reported successful findings from their Phase 1/2 clinical testing of the CHM gene for treatment of choroideremia. Choroideremia is a rare disease affecting mostly males that leads to blindness. In the multicentre clinical trial, six male patients (aged 35—63 years) all showed improvement after replacement of the malfunctioning gene. The [Read More]